Mergers and Acquisitions
In over 300 transactions involving assets of more than Euro 10bn in transaction values we have proven that FERBER & CO. stands for delivering outstanding results to its clients.
As every situation and every client is different our M&A advice will always be adapted to ensure optimal results.
M&A transactions require decisions from companies and managers of long-term and strategic importance. Particularly in medium-sized or family-owned businesses the objectives usually have a unique character and are of paramount importance to the companies and their owners. In typical cases those decisions have to be carried out without significant prior experience.
Therefore, a professional, independent advisor is required to join forces with the shareholders and management. Comprehensive know-how and long-term experience through a large number of concluded transactions enable us to decisively contribute to the optimization of the decision-making process and the success of the transaction.
Throughout our numerous assignments we have been consistently striving for professional excellence. Therefore we are known for combining the experience of our partners with transactions of various sizes and complexities with our in-depth market knowledge in all major sectors and geographies.
Recent Transactions
in Mergers & Acquisitions
Cooper Consumer Health SAS has sold OTOWAXOL
its German earwax removal OTC brand to InfectoPharm Arzneimittel und Consilium GmbH.
We acted as advisor to the sellers.
FR L’Osteria SE and its shareholders have sold a majority stake to McWin Partners.
We acted as advisor to FR L’Osteria SE and its shareholders.
Dermapharm has acquired Arkopharma SE from Montagu Private Equity LLP.
We acted as advisor to the buyer.
Apurano Pharmaceuticals successfully completed the realignment of its shareholder base including a private placement to secure its further expansion.
We initiated the transaction and advised Apurano Pharmaceuticals in its funding round.
We initiated the transaction and acted as advisor to Heinz-Peter Fichter and Apotal group.
Capiton has assumed a minority ownership stake in Alphapet Ventures, a leader in the premium pet food market, acquiring Healthfood24 (Wolfsblut).
We initiated the transaction and advised Capiton and Alphapet Ventures on the realignment of the shareholder base.
Dermapharm has acquired Allergopharma GmbH & Co. KG, a subsidiary of Merck KGaA.
We acted as advisor to the buyer.
Zur Rose Group and DocMorris have acquired medpex.
We acted as advisor to the buyer.
Dermapharm AG has acquired Euromed from Riverside.
We acted as advisor to the buyer.
Point Rouge has acquired ascopharm from Pagoda and Adiuva Capital.
We acted as advisor to the buyer.
Aenova, a portfolio company of BC Partners, has sold 100% of the shares in Euro Vital Pharma to Capiton and the management.
We initiated the transaction and acted as advisor to the sellers.
Zur Rose Group and DocMorris have acquired Apotheke am Rothenbaum (apo-rot).
We initiated the transaction and acted as advisor to the buyer.
Advent International has acquired Deutsche Fachpflege Gruppe from Chequers Capital.
We initiated the transaction and acted as advisor to the buyer.
Dermapharm AG has acquired 100% of the shares in Trommsdorff from Grupo Ferrer.
We initiated the transaction and acted as advisor to the buyer.
Dermapharm AG has acquired 100% of the shares in Strathmann.
We acted as advisor to the buyer.
Trilantic Capital Partners has acquired 100% of the shares in Oberberg Klinik group from Odewald & Compagnie.
We acted as advisor to the buyer.